Trexquant Investment’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-120,065
| Closed | -$2.3M | – | 1899 |
|
|
2024
Q4 | $2.3M | Sell |
120,065
-22,576
| -16% | -$433K | 0.03% | 809 |
|
|
2024
Q3 | $3.25M | Buy |
142,641
+100,817
| +241% | +$2.29M | 0.04% | 640 |
|
|
2024
Q2 | $544K | Buy |
+41,824
| New | +$544K | 0.01% | 1217 |
|
|
2023
Q1 | – | Sell |
-35,887
| Closed | -$1.05M | – | 1806 |
|
|
2022
Q4 | $1.05M | Buy |
+35,887
| New | +$1.05M | 0.03% | 624 |
|
|
2018
Q4 | – | Sell |
-669
| Closed | -$56K | – | 1328 |
|
|
2018
Q3 | $56K | Buy |
+669
| New | +$56K | ﹤0.01% | 909 |
|
|
2018
Q2 | – | Sell |
-1,050
| Closed | -$110K | – | 1251 |
|
|
2018
Q1 | $110K | Sell |
1,050
-13
| -1% | -$1.36K | 0.01% | 1012 |
|
|
2017
Q4 | $166K | Buy |
+1,063
| New | +$166K | 0.02% | 970 |
|